Auxilium Pharmaceuticals, Inc. Lowers 2014 Financial Guidance
http://online.wsj.com/article/PR-CO-20140429-918730.html
CHESTERBROOK, Pa., April 29, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that it is reducing its financial guidance for the full year 2014 due primarily to lower-than-expected revenues from Testim(R) testosterone gel.
http://online.wsj.com/article/PR-CO-20140429-918730.html
CHESTERBROOK, Pa., April 29, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that it is reducing its financial guidance for the full year 2014 due primarily to lower-than-expected revenues from Testim(R) testosterone gel.
